NFATc2 shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images

NFATc2 shRNA Plasmid (h)

Be the first to write a review!

Citations:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
NFATc2 shRNA Plasmid (h)

Product Specs
ItemNFATc2 shRNA Plasmid (h)
CompanySanta Cruz Biotechnology, Inc.
Price $592.00Supplier Page View Company Product Page
Catalog Numbersc-36055-SH
Quantity20 µg
RNA TypeshRNA Clones
Vector Type (Standardized)Lentiviral
TypeshRNA Plasmid
Specieshuman
NCBI Full Gene Namenuclear factor of activated T cells 2
NCBI Gene AliasesJCOSL, NFAT1, NFATP

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Chronic Alcohol Exposure Promotes Cancer Stemness and Glycolysis in Oral/Oropharyngeal Squamous Cell Carcinoma Cell Lines by Activating NFAT SignalingInternational journal of molecular sciencesAugust 29, 2022Nguyen A, Kim AH, Kang MK, Park NH, Kim RH, Kim Y, Shin KH.

(2) TGF-β1-stimulation of NFATC2 and ATF3 proteins and their interaction for matrix metalloproteinase 13 expression in human breast cancer cellsInternational journal of biological macromoleculesDecember 1, 2021Rohini M, Vairamani M, Selvamurugan N.

(3) Identification of Ascomycin against Zika virus infection through screening of natural product libraryAntiviral researchDecember 1, 2021Zhou L, Zhou J, Chen T, Chi X, Liu X, Pan S, Chen W, Wu T, Lin T, Zhang X, et al.

(4) OSW-1 inhibits tumor growth and metastasis by NFATc2 on triple-negative breast cancerCancer medicineAugust 1, 2020Ding X, Li Y, Li J, Yin Y.

(5) Increased HERV-E clone 4-1 expression contributes to DNA hypomethylation and IL-17 release from CD4(+) T cells via miR-302d/MBD2 in systemic lupus erythematosusCell communication and signaling : CCSAugust 14, 2019Wang X, Zhao C, Zhang C, Mei X, Song J, Sun Y, Wu Z, Shi W.

(6) Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signallingBritish journal of cancerMay 9, 2017Han S, Meng L, Jiang Y, Cheng W, Tie X, Xia J, Wu A.

(7) Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progressionOncotargetMarch 22, 2016Eriksson J, Le Joncour V, Nummela P, Jahkola T, Virolainen S, Laakkonen P, Saksela O, Hölttä E.

(8) PMA and ionomycin induce glioblastoma cell death: activation-induced cell-death-like phenomena occur in glioma cellsPloS oneJanuary 1, 2013Han S, Tie X, Meng L, Wang Y, Wu A.

Be the First to Write a Review!